{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:44:00Z","timestamp":1760060640595,"version":"build-2065373602"},"reference-count":128,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n (SECIHTI, former CONACyT)","award":["273116","482690","736271","416277"],"award-info":[{"award-number":["273116","482690","736271","416277"]}]},{"name":"National Institute of Cancer (INCan)","award":["273116","482690","736271","416277"],"award-info":[{"award-number":["273116","482690","736271","416277"]}]},{"name":"Tecnologico de Monterrey","award":["273116","482690","736271","416277"],"award-info":[{"award-number":["273116","482690","736271","416277"]}]},{"name":"SECIHTI MS fellowships","award":["273116","482690","736271","416277"],"award-info":[{"award-number":["273116","482690","736271","416277"]}]},{"name":"SECIHTI PhD fellowship","award":["273116","482690","736271","416277"],"award-info":[{"award-number":["273116","482690","736271","416277"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Prostate cancer (PCa) is the second most frequent tumor and the fifth leading cause of cancer-related death in men worldwide. PCa shows the largest clinical disparities across Asian, Caucasian, and African descendants among all cancer types, proving that the ethnic genetic background plays a significant role in PCa. Androgen Receptor (AR) gene malfunctioning represents the most prevalent cause of PCa. AR also displays a broad spectrum of genetic variability across ethnic backgrounds differently associated with cancer risk. We conducted a massive sequencing analysis of 15 genes highly relevant for PCa or the AR activation pathway in biopsies from 64 tumors and 36 benign prostate samples from Mexican patients. We identified 3414 genomic mutations and observed that AR, SPOP, TP53, FOXA1, and MTOR had the highest rate of pathogenic mutations in tumors, evidencing their relevance in PCa. AR showed 13 unique mutations, followed by SPOP (6), TP53 (5), FOXA1 (4), and MTOR (3). We discovered 19 novel mutations specific of Hispanic patients, a population only scarcely studied, thus adding critical information on the genetic diversity of the mutational landscape in genes key for PCa. We discuss the clinical relevance of these mutations and predict the structural consequences on the proteins. Mutations in FOXA1 showed significant negative association with patient survival and might be used as novel PCa markers, at least for Hispanic men.<\/jats:p>","DOI":"10.3390\/ijms26188758","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:27:12Z","timestamp":1757500032000},"page":"8758","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep Sequencing Reveals Novel Mutations in Androgen Receptor-Related Genes in Prostate Cancer"],"prefix":"10.3390","volume":"26","author":[{"given":"Abraham","family":"Pedroza-Torres","sequence":"first","affiliation":[{"name":"C\u00e1tedra SECIHTI-Cl\u00ednica de C\u00e1ncer Hereditario, National Institute of Cancer (Instituto Nacional de Cancerolog\u00eda, INCan), Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noem\u00ed","family":"Baranda-Avila","sequence":"additional","affiliation":[{"name":"Laboratory of mRNA and Cancer, Unit of Biomedical Research on Cancer, National Institute of Cancer (Instituto Nacional de Cancerolog\u00eda, INCan), Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge L.","family":"Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Laboratory of mRNA and Cancer, Unit of Biomedical Research on Cancer, National Institute of Cancer (Instituto Nacional de Cancerolog\u00eda, INCan), Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maricruz","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Laboratory of mRNA and Cancer, Unit of Biomedical Research on Cancer, National Institute of Cancer (Instituto Nacional de Cancerolog\u00eda, INCan), Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Laboratory of mRNA and Cancer, Unit of Biomedical Research on Cancer, National Institute of Cancer (Instituto Nacional de Cancerolog\u00eda, INCan), Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2669-4364","authenticated-orcid":false,"given":"Blanca L.","family":"Torres","sequence":"additional","affiliation":[{"name":"Laboratory of mRNA and Cancer, Unit of Biomedical Research on Cancer, National Institute of Cancer (Instituto Nacional de Cancerolog\u00eda, INCan), Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Jim\u00e9nez-R\u00edos","sequence":"additional","affiliation":[{"name":"Department of Oncologic Urology, National Institute of Cancer (INCan), Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1871-4311","authenticated-orcid":false,"given":"Alfonso","family":"M\u00e9ndez-Tenorio","sequence":"additional","affiliation":[{"name":"Laboratory of Biotechnology and Genomic Bioinformatics, National School of Sciences, National Polytechnic Institute (Instituto Polit\u00e9cnico Nacional), Mexico City 07840, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5458-7201","authenticated-orcid":false,"given":"Rosa Mar\u00eda","family":"\u00c1lvarez-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Cl\u00ednica de C\u00e1ncer Hereditario, National Institute of Cancer (Instituto Nacional de Cancerolog\u00eda, INCan), Mexico City 14080, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5318-4443","authenticated-orcid":false,"given":"Greco","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Laboratory of mRNA and Cancer, Unit of Biomedical Research on Cancer, National Institute of Cancer (Instituto Nacional de Cancerolog\u00eda, INCan), Mexico City 14080, Mexico"},{"name":"Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City 14380, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"ref_1","unstructured":"Wild, C.P., Weiderpass, E., and Stewart, B.W. (2020). World Cancer Report. Cancer Research for Cancer Prevention, International Agency for Research on Cancer and World Health Organization."},{"key":"ref_2","unstructured":"Ferlay, J., Ervik, M., Laversanne, M., Colombet, N., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2024). Global Cancer Observatory: Cancer Today, World Health Organization. Available online: https:\/\/gco.iarc.who.int\/today."},{"key":"ref_3","unstructured":"International Agency for Research on Cancer (2022). Cancer Today. Data Version: Globocan 2022, World Health Organization. Available online: https:\/\/gco.iarc.who.int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: Planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbamcr.2016.02.016","article-title":"The molecular and cellular origin of human prostate cancer","volume":"1863","author":"Packer","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"a030411","DOI":"10.1101\/cshperspect.a030411","article-title":"Histopathology of prostate cancer","volume":"7","author":"Humphrey","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., and Mashele, S. (2022). Prostate cancer review: Genetics, diagnosis, treatment options, and alternative approaches. Molecules, 27.","DOI":"10.3390\/molecules27175730"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"a030361","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Porcaro, A.B., Tafuri, A., Inverardi, D., Amigoni, N., Sebben, M., Pirozzi, M., Processali, T., Rizzetto, R., Shakir, A., and Cerrato, C. (2020). Incidental prostate cancer after transurethral resection of the prostate: Analysis of incidence and risk factors in 458 patients. Minerva Urol. Nefrol., online ahead of print.","DOI":"10.23736\/S2724-6051.19.03564-1"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"a030387","DOI":"10.1101\/cshperspect.a030387","article-title":"Prostate cancer disparities by race and ethnicity: From nucleotide to Neighborhood","volume":"8","author":"Rebbeck","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.21037\/tau.2017.09.11","article-title":"Racial disparities and considerations for active surveillance of prostate cancer","volume":"7","author":"Jiang","year":"2018","journal-title":"Transl. Androl. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Tan, S.H., Petrovics, G., and Srivastava, S. (2018). Prostate gancer genomics: Recent advances and the prevailing underrepresentation from racial and ethnic minorities. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041255"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5687212","DOI":"10.1155\/2017\/5687212","article-title":"Biomarkers of prostatic cancer: An attempt to categorize patients into prostatic carcinoma, benign prostatic hyperplasia, or prostatitis based on serum prostate specific antigen, prostatic acid phosphatase, calcium, and phosphorus","volume":"2017","author":"Sarwar","year":"2017","journal-title":"Prostate Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cam4.549","article-title":"Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score","volume":"5","author":"Herget","year":"2016","journal-title":"Cancer Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.2018.0154","article-title":"Effect of a low-intensity PSA-based ccreening intervention on prostate cancer mortality: The CAP randomized clinical trial","volume":"319","author":"Martin","year":"2018","journal-title":"J. Am. Med. Asoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.21037\/tau.2017.08.23","article-title":"Expanded criteria for active surveillance in prostate cancer: A review of the current data","volume":"7","author":"Jones","year":"2018","journal-title":"Transl. Androl. Urol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1758835918776920","DOI":"10.1177\/1758835918776920","article-title":"Precision medicine applications in prostate cancer","volume":"10","author":"McCrea","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1913-9","article-title":"Patterns of somatic structural variation in human cancer genomes","volume":"578","author":"Li","year":"2020","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"a034942","DOI":"10.1101\/cshperspect.a034942","article-title":"The genomics of prostate cancer: A historic perspective","volume":"31","author":"Rubin","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ctrv.2015.07.001","article-title":"Molecular landscape of prostate cancer: Implications for current clinical trials","volume":"41","author":"Khemlina","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","article-title":"Punctuated evolution of prostate cancer genomes","volume":"153","author":"Baca","year":"2013","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","article-title":"Analyses of non-coding somatic drivers in 2,658 cancer whole genomes","volume":"578","author":"Rheinbay","year":"2020","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1593\/neo.131704","article-title":"SPOP mutations in prostate cancer across demographically diverse patient cohorts","volume":"16","author":"Blattner","year":"2014","journal-title":"Neoplasia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pros.21265","article-title":"TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients","volume":"71","author":"Tsusuki","year":"2011","journal-title":"Prostate"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12397","DOI":"10.1007\/s13277-016-5116-9","article-title":"TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer","volume":"37","author":"Jiang","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/aje\/kwx235","article-title":"TMPRSS2:ERG gene fusions in prostate cancer of west African men and a meta-analysis of racial differences","volume":"186","author":"Zhou","year":"2017","journal-title":"Am. J. Epidemiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/pros.23833","article-title":"Comparative analysis of p16 expression among African American and European American prostate cancer patients","volume":"79","author":"Wong","year":"2019","journal-title":"Prostate"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8356","DOI":"10.18632\/oncotarget.14198","article-title":"Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians","volume":"8","author":"Shina","year":"2017","journal-title":"Oncotarget"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","article-title":"A genomic and epigenomic atlas of prostate cancer in Asian populations","volume":"580","author":"Li","year":"2020","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2018.04.083","article-title":"Androgen receptor-targeted treatments for prostate cancer: 35 years\u2019 Progress with antiandrogens","volume":"200","author":"Crawford","year":"2018","journal-title":"J. Urol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2014.18","article-title":"Androgen receptor: Structure, role in prostate cancer and drug discovery","volume":"36","author":"Tan","year":"2015","journal-title":"Acta Pharma. Sin."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Aurilio, G., Cimadamore, A., Mazzucchelli, R., Lopez-Beltran, A., Verri, E., Scarpelli, M., Massari, F., Cheng, L., Santoni, M., and Montironi, R. (2020). Androgen Receptor signaling pathway in prostate cancer: From genetics to clinical applications. Cells, 9.","DOI":"10.3390\/cells9122653"},{"key":"ref_36","first-page":"235","article-title":"New opportunitie for targeting the Androgen receptor in prostate cancer","volume":"15","author":"Centenera","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ng0495-401","article-title":"In vivo amplification of the androgen receptor gene and progression of human prostate cancer","volume":"9","author":"Visakorpi","year":"1995","journal-title":"Nat. Genet."},{"key":"ref_38","first-page":"3550","article-title":"Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer","volume":"61","author":"Linja","year":"2001","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/humu.22046","article-title":"The androgen receptor gene mutations database: 2012 Update","volume":"33","author":"Gottlieb","year":"2012","journal-title":"Hum. Mut."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10555-013-9474-0","article-title":"Androgen receptor signaling in prostate cancer","volume":"33","author":"Culig","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zaman, N., Giannopoulos, P.N., Chowdhury, S., Bonneil, E., Thibault, P., Wang, E., Trifiro, M., and Paliouras, M. (2014). Proteomic-coupled-network analysis of T877A Androgen Receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113190"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3892\/ijmm.2013.1474","article-title":"Association between CAG repeat polymorphisms and the risk of prostate cancer: A meta-analysis by race, study design and the number of (CAG) n repeat polymorphisms","volume":"32","author":"Sun","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e7258","DOI":"10.1097\/MD.0000000000007258","article-title":"Association between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer: A systematic review and meta-analysis","volume":"96","author":"Qin","year":"2017","journal-title":"Medicine"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Weng, H., Li, S., Huang, J.Y., He, Z.Q., Meng, X.Y., Cao, Y., Fang, C., and Zeng, X.T. (2017). Androgen receptor gene polymorphisms and risk of prostate cancer: A meta-analysis. Sci. Rep., 7.","DOI":"10.1038\/srep40554"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s11033-011-1014-9","article-title":"The CAG repeat polymorphism of androgen receptor gene and prostate cancer: A meta-analysis","volume":"39","author":"Gu","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/pro.3496","article-title":"The nuclear receptor super-family: A structural perspective","volume":"27","author":"Weikum","year":"2018","journal-title":"Protein Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0006-291X(03)00902-1","article-title":"Implications of a polyglutamine tract in the function of the human androgen receptor","volume":"306","author":"Callewaert","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/jme.0.0250085","article-title":"Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: Specificity in prostate and non-prostate cell lines","volume":"25","author":"Beilin","year":"2000","journal-title":"J. Mol. Endocrinol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41586-019-1347-4","article-title":"Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer","volume":"571","author":"Parolia","year":"2019","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13238-020-00786-8","article-title":"Pioneer of prostate cancer: Past, present and the future of FOXA1","volume":"12","author":"Teng","year":"2021","journal-title":"Prot. Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41586-019-1318-9","article-title":"FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes","volume":"571","author":"Adams","year":"2019","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhu, J., Wei, Y., Deng, F., Zhou, Y., Yang, Z., and Ma, Y. (2024). The role of FOXA1 in human normal development and its functions in sex hormone-related cancers. Front. Biosc., 29.","DOI":"10.31083\/j.fbl2906225"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0092-8674(00)80280-9","article-title":"Cocrystal structure of the messenger RNA 5\u2032 cap-binding protein (eIF4E) bound to 7-methyl-GDP","volume":"89","author":"Marcotrigiano","year":"1997","journal-title":"Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj3620539","article-title":"Crystal structures of 7-methylguanosine 5\u2032-triphosphate (m7GTP)- and P1-7-methylguanosine-P3-adenosine-5\u2032, 5\u2032-triphosphate (m7GpppA)-bound human full-lenght eukaryotic initiation factor 4E: Biological importance of the C-terminal flexible region","volume":"362","author":"Tomoo","year":"2002","journal-title":"Biochem. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","article-title":"Regulation and function of the human HSP90AA1 gene","volume":"570","author":"Zuehlke","year":"2015","journal-title":"Gene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0092-8674(00)80314-1","article-title":"Identification and structural characterization of the ATP\/ADP-binding site in the Hsp90 molecular chaperone","volume":"90","author":"Prodromou","year":"1997","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Petrosino, M., Novak, L., Pasquo, A., Turina, P., Capriotti, E., Minicozzi, V., Consalvi, V., and Chiaraluce, R. (2023). The complex impact of cancer-related missense mutations on the stability and on the biophysical and biochemical properties of MAPK1 and MAPK3 somatic variants. BMC Hum. Genet., 17.","DOI":"10.1186\/s40246-023-00544-x"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Sulaimani, M.N., Ahmed, S., Anjum, F., Mohammad, T., Shamsii, A., Dohare, R., and Hassan, M.I. (2025). Structure-guided identification of mitogenactivated protein kinase-1 inhibitors towards anticancer therapeutics. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0311954"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"mTOR kinase structure, mechanism and regulation","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Marafie, S.K., Al-Mulla, F., and Abubaker, J. (2024). mTOR: Its critical role in metabolic diseases, cancer, and the aging process. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25116141"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1093\/emboj\/cdg326","article-title":"A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation","volume":"22","author":"Yu","year":"2003","journal-title":"EMBO J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"38264","DOI":"10.1074\/jbc.M111.277012","article-title":"Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_64","unstructured":"Wild, C.P., Weiderpass, E., and Stewart, B.W. (2020). Prostate cancer. Challenges for prevention, detection and treatment. World Cancer Report, World Health Organization. International Agency for Research in Cancer."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: Improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acid Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/475163a","article-title":"Genomics for the world","volume":"475","author":"Bustamante","year":"2011","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/4371241a","article-title":"Understanding human diversity","volume":"437","author":"Goldstein","year":"2005","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","article-title":"The missing diversity in human genetic studies","volume":"177","author":"Sirugo","year":"2019","journal-title":"Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1055-9965.EPI-17-0169","article-title":"Genome-wide association studies of cancer in diverse populations","volume":"27","author":"Park","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1039\/c1ib00038a","article-title":"Dynamic rewiring of the androgen receptor protein interaction network correlates with prostate cancer clinical outcomes","volume":"3","author":"Paliouras","year":"2011","journal-title":"Integr. Biol."},{"key":"ref_72","first-page":"2861","article-title":"Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers","volume":"54","author":"Gaddipati","year":"1994","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/01.LAB.0000107262.40402.44","article-title":"Androgen receptor mutations in high-grade prostate cancer before hormonal therapy","volume":"83","author":"Thompson","year":"2003","journal-title":"Lab. Investig."},{"key":"ref_74","first-page":"277","article-title":"Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence","volume":"2","author":"Tilley","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/ijc.22479","article-title":"Somatic mutations at the trinucleotide repeats of androgen receptor gene in male epatocellular carcinoma","volume":"120","author":"Yeh","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11329","article-title":"Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations","volume":"488","author":"Pugh","year":"2012","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Lefebvre, C., Bachelot, T., Filleron, T., Pedrero, M., Campone, M., Soria, J.C., Massard, C., L\u00e9vy, C., Arnedos, M., and Lacroix-Triki, M. (2016). Mutational profile of metastatic breast cancers: A retrospective analysis. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002201"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.celrep.2016.03.075","article-title":"Genomic correlates of immune-cell infiltrates in colorectal carcinoma","volume":"15","author":"Giannakis","year":"2016","journal-title":"Cell Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsbmb.2008.11.010","article-title":"Short alleles of both GGN and CAG repeats at the exon-1 of the androgen receptor gene are associated to increased PSA staining and a higher Gleason score in human prostatic cancer","volume":"113","author":"Cabrera","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1038\/emboj.2011.328","article-title":"Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer","volume":"30","author":"Sahu","year":"2011","journal-title":"EMBO J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BSR20110046","article-title":"FOXA1: A transcription factor with parallel functions in development and cancer","volume":"32","author":"Bernardo","year":"2012","journal-title":"Biosci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.ajpath.2011.10.021","article-title":"FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer","volume":"180","author":"Gerhardt","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1158\/0008-5472.CAN-12-3468","article-title":"Androgen receptor-independent function of FoxA1 in prostate cancer metastasis","volume":"73","author":"Jin","year":"2013","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_85","unstructured":"Cancer Genome Atlas Research Network (2015). The molecular taxonomy of primary prostate cancer. Cell, 163, 1011\u20131025."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Espiritu, S.M.G., Liu, L.Y., Rubanova, Y., Bhandari, V., Espiritu, S.M.G., Holgersen, E.M., Szyca, L.M., Espiritu, S.M.G., Fox, N.S., and Chua, M.L. (2018). The evolutionary landscape of localized prostate cancers drives clinical aggression. Cell, 173.","DOI":"10.1016\/j.cell.2018.03.029"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1158\/2159-8290.CD-16-0960","article-title":"Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations","volume":"7","author":"Huang","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/pros.23830","article-title":"SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged","volume":"79","author":"Safont","year":"2019","journal-title":"Prostate"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41422-019-0204-1","article-title":"Altered chromatin recruitment by FOXA1 mutations promotes androgen independence and prostate cancer progression","volume":"29","author":"Xu","year":"2019","journal-title":"Cell Res."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Shorning, B.Y., Dass, M.S., Smalley, M.J., and Pearson, H.B. (2020). The PI3K-AKT-mTOR pathway and prostate cancer: At the crossroads of AR, MAPK, and WNT signaling. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124507"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Proud, C.G. (2019). Phosphorylation and signal transduction pathways in translational control. Cold Spring Harb. Perspect. Biol., 11.","DOI":"10.1101\/cshperspect.a033050"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Makwana, V., Rudrawar, S., and Anoopkumar-Dukie, S. (2021). Signalling transduction of O-GlcNAcylation and PI3K\/AKT\/mTOR-axis in prostate cancer. Biochim. Biophys. Acta Mol. Basis Dis., 1867.","DOI":"10.1016\/j.bbadis.2021.166129"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"110534","DOI":"10.1016\/j.celrep.2022.110534","article-title":"The mTOR chromatin-bound interactome in prostate cancer","volume":"38","author":"Dufor","year":"2022","journal-title":"Cell Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1541-7786.MCR-23-0087","article-title":"Canonical and nuclear mTOR specify distinct transcriptional programs in androgen-dependent prostate cancer cells","volume":"22","author":"Chen","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1101\/gad.299958.117","article-title":"Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer","volume":"31","author":"Dufor","year":"2017","journal-title":"Genes Dev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.trecan.2020.01.015","article-title":"DNA-PK, nuclear mTOR, and the androgen pathway in prostate cancer","volume":"6","author":"Giguere","year":"2020","journal-title":"Trends Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jmcb\/mjx002","article-title":"Anatomy of Mdm2 and Mdm4 in evolution","volume":"9","author":"Tan","year":"2017","journal-title":"J. Mol. Cell Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1093\/emboj\/17.9.2513","article-title":"The human oncoprotein MDM2 arrests the cell cycle: Elimination of its cell-cycle-inhibitory function induces tumorigenesis","volume":"17","author":"Brown","year":"1998","journal-title":"EMBO J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1101\/gad.1941710","article-title":"The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor","volume":"24","author":"Manfredi","year":"2010","journal-title":"Genes Dev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"18771","DOI":"10.1074\/jbc.M413387200","article-title":"Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair","volume":"280","author":"Alt","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/onc.2011.343","article-title":"MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cells","volume":"31","author":"Gu","year":"2012","journal-title":"Oncogene"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.canlet.2013.02.035","article-title":"Mdm2 increases cellular invasiveness by binding to and stabilizing the Slug mRNA","volume":"335","author":"Jung","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/pharmrev.123.001026","article-title":"MDM2 Inhibitors for cancer therapy: The past, present, and future","volume":"76","author":"Wang","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"31825","DOI":"10.18632\/oncotarget.3923","article-title":"MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer","volume":"7","author":"Xue","year":"2016","journal-title":"Oncotarget"},{"key":"ref_105","first-page":"e230017","article-title":"MDM2 regulates the stability of AR, AR-V7, and TM4SF3 proteins in prostate cancer","volume":"4","author":"Khatiwada","year":"2024","journal-title":"Endocr. Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/0008-5472.CAN-18-1753","article-title":"Constant degradation of the androgen receptor by MDM2 conserves prostate cancer stem cell integrity","volume":"79","author":"Williams","year":"2019","journal-title":"Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/brv.13005","article-title":"eIF4E as a molecular wildcard in metazoans RNA metabolism","volume":"98","year":"2023","journal-title":"Biol. Rev. Cambr. Phil. Soc."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1042\/BST20150126","article-title":"Signalling to eIF4E in cancer","volume":"43","author":"Siddiqui","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/pros.20410","article-title":"Expression of mTOR signaling pathway markers in prostate cancer progression","volume":"66","author":"Kremer","year":"2006","journal-title":"Prostate"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Mamane, Y., Petroulakis, E., Martineau, Y., Sato, T.A., Larsson, O., Rajasekhar, V., and Sonenberg, N. (2007). Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000242"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.molcel.2012.04.004","article-title":"Translational homeostasis via the mRNA Cap-binding protein, eIF4E","volume":"46","author":"Yanagiya","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2015.05.049","article-title":"Differential requirements for eIF4E dose in normal development and cancer","volume":"162","author":"Truitt","year":"2015","journal-title":"Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/pros.22761","article-title":"Extracellular Hsp90 mediates an NF-kappaB dependent inflammatory stromal program: Implications for the prostate tumor microenvironment","volume":"74","author":"Bohonowych","year":"2014","journal-title":"Prostate"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","article-title":"ERK signalling: A master regulator of cell behaviour, life and fate","volume":"21","author":"Lavoie","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_116","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2019.01.039","article-title":"Targeting ERK1\/2 protein-serine\/threonine kinases in human cancers","volume":"142","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez, G., Ram\u00edrez, J.L., Pedroza-Torres, A., Herrera, L.A., and Jim\u00e9nez-R\u00edos, M.A. (2019). The secret life of translation initiation in prostate cancer. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.00014"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Paluvai, H., Shanmukha, K.D., Tyedmers, J., and Backs, J. (2023). Insights into the function of HDAC3 and NCoR1\/NCoR2 co-repressor complex in metabolic diseases. Front. Mol. Biosci., 10.","DOI":"10.3389\/fmolb.2023.1190094"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/cbin.10973","article-title":"Role of NCoR1 in mitochondrial function and energy metabolism","volume":"42","author":"TI","year":"2018","journal-title":"Cell Biol. Int."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"St-Jean, S., De Castro, A.C., Lecours, M., Jones, C., Rivard, N., Rodier, F., Perreault, N., and Boudreau, F. (2021). NCOR1 sustains colorectal cancer cell growth and protects against cellular senescence. Cancers, 13.","DOI":"10.3390\/cancers13174414"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-15-1983","article-title":"Nuclear receptor corepressor 1 expression and output declines with prostate cancer progression","volume":"22","author":"Lopez","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1038\/s41467-022-34863-9","article-title":"Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis","volume":"13","author":"Aylon","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-019-1056-z","article-title":"Genomic characterization of metastatic breast cancers","volume":"569","author":"Bertucci","year":"2019","journal-title":"Nature"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Shu, S., Li, Z., Liu, L., Ying, X., Zhang, Y., Wang, T., Zhou, X., Jiang, P., and Lv, W. (2022). HPV16 E6-activated OCT4 promotes cervical cancer progression by suppressing p53 expression via co-repressor NCOR1. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.900856"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Lin, A., Qiu, Z., Zhang, J., and Luo, P. (2021). Effect of NCOR1 mutations on immune microenvironment and efficacy of immune checkpoint inhibitors in patient with bladder cancer. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.630773"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/2211-5463.13004","article-title":"NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer","volume":"10","author":"Tang","year":"2020","journal-title":"FEBS Open Bio"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: The catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/18\/8758\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:42:22Z","timestamp":1760035342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/18\/8758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":128,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26188758"],"URL":"https:\/\/doi.org\/10.3390\/ijms26188758","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,9,9]]}}}